NLRP3 and amyotrophic lateral sclerosis: In a recent study, acute treatment with an NLRP3-specific inhibitor did not reduce spinal cord inflammation in SOD1G93A mice, suggesting that multiple inflammasomes may be activated in ALS and that inhibition of NLRP3 alone may not be sufficient to block inflammation [182].